Sort
16,300 grants matching “fatty liver disease”
Regulation of Mitochondrial Biogenesis and Function by DsbA-L in the Liver
$339,818Alan Frazer · University Of Texas Hlth Science Center · R01 · FY2021 · DK
Regulation of Mitochondrial Biogenesis and Function by DsbA-L in the Liver
$339,818Feng Liu · University Of Texas Hlth Science Center · R01 · FY2019 · DK
Regulation of Mitochondrial Biogenesis and Function by DsbA-L in the Liver
$339,818Alan Frazer · University Of Texas Hlth Science Center · R01 · FY2020 · DK
Vascular Inflammation, IL-6 and the Renin-Angiotensin System
$339,750Allan R. Brasier · University Of Texas Med Br Galveston · R01 · FY2011 · HL
Vascular Inflammation, IL-6 and the Renin-Angiotensin System
$339,750Allan R. Brasier · University Of Texas Med Br Galveston · R01 · FY2009 · HL
Hepatic Steatosis and the Lipid Metabolome
$339,750Ghulam As Ansari · University Of Texas Med Br Galveston · R01 · FY2007 · AA
Hepatic Steatosis and the Lipid Metabolome
$339,750Ghulam As Ansari · University Of Texas Med Br Galveston · R01 · FY2008 · AA
Hepatic Steatosis and the Lipid Metabolome
$339,750Ghulam As Ansari · University Of Texas Med Br Galveston · R01 · FY2009 · AA
Vascular Inflammation, IL-6 and the Renin-Angiotensin System
$339,750Allan R. Brasier · University Of Texas Med Br Galveston · R01 · FY2008 · HL
Immune Mechanisms of HCV Persistence and Pathogenesis
$339,750Jiaren Sun · University Of Texas Med Br Galveston · R01 · FY2007 · AI
Vascular Inflammation, IL-6 and the Renin-Angiotensin System
$339,750Allan R. Brasier · University Of Texas Med Br Galveston · R01 · FY2010 · HL
Transforming Growth Factor - Beta Superfamily Signaling in Diabetes and Obesity
$339,726Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Air Pollution on Adiposity and Vascular Dysfunction: White or Brown Matters?
$339,694Qinghua Sun · Ohio State University · R01 · FY2014 · ES
Determining the structural-and functional-level effects of diet-specific interventions on the gut-microbiota of a diverse sample of Southern United States adults
$339,694Tiffany Lashaun Carson · University Of Alabama At Birmingham · R01 · FY2020 · CA
Defining how obesity shapes immunity and the success of cancer immunotherapy
$339,625Ryan M Teague · Saint Louis University · R01 · FY2022 · CA
Defining how obesity shapes immunity and the success of cancer immunotherapy
$339,625Ryan M Teague · Saint Louis University · R01 · FY2023 · CA
Time-restricted feeding and breast cancer
$339,552Nicholas J Webster · University Of California, San Diego · R01 · FY2022 · CA
Stress Signaling Pathways in Toxicity and Disease
$339,529Michael Karin · University Of California, San Diego · R01 · FY2011 · ES
Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis
$339,488Hua Xiao · Michigan State University · R01 · FY2015 · CA
Development of CB1 Monoclonal Antibodies for Treating NASH
$339,478Benjamin Jacob Doranz · Integral Molecular · R44 · FY2020 · DK
Optimizing medium-chain lipids for the treatment of long-chain fatty acid oxidation disorders
$339,414Eric S Goetzman · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HD
FATTY ACID TRANSPORTER: REGULATION, IDENTIFICATION
$339,313Nada A. Abumrad · Washington University · R01 · FY2015 · DK
FATTY ACID TRANSPORTER: REGULATION, IDENTIFICATION
$339,313Nada A. Abumrad · Washington University · R01 · FY2016 · DK
FATTY ACID TRANSPORTER: REGULATION, IDENTIFICATION
$339,313Nada A. Abumrad · Washington University · R01 · FY2017 · DK
Hepatocellular Transport of Biliary Phospholipids
$339,305David E Cohen · Brigham And Women'S Hospital · R01 · FY2009 · DK